Anthony Minnah

Anthony Minnah is a Ph.D. student in the Department of Pharmacology under the guidance of Dr. Faye Rogers. Anthony received his Bachelor of Science in Biomedical Engineering (Honors) from Brown University. There, he was a recipient of the Karen T Romer Undergraduate Teaching and Research Award (UTRA) for his research on preventing surgical site infections (SSIs) in orthopedic surgery using nanoparticle formulations. Post-graduation, Anthony spent four impactful years at Travera, a Boston-based biotech startup, motivated by applying his knowledge in biomedical engineering to a company involved in applying translational research to solve a critical need directly. In his role, he worked as part of a team leveraging a microfluidic chip technology from MIT to measure the mass of individual cells, providing a robust ex-vivo assessment of drug response based on cell size and density changes. The research underscored the effectiveness of a predictive biomarker across a wide range of cancer malignancies and therapeutic options.

Anthony’s current research interest lies in understanding the role of gene amplification and its implications in the pathophysiology of specific cancers, particularly ovarian cancer. In line with that objective, he’s actively involved in pioneering an innovative precision medicine platform for ovarian cancers with gene amplification, offering a promising alternative to conventional therapies.